Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?

BACKGROUND: Hepatitis B virus (HBV) chronic infection affects up to 240 million people in the world and it is a common cause of cirrhosis and hepatocellular carcinoma (HCC). HBV covalently closed circular DNA (cccDNA) plays an essential role in HBV persistence and replication. Current pharmacologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, Sonia, Guerra, Adriana-René, Carreira, Lourdes, Ferrer, Juan-Ángel, Gutiérrez, María-Luisa, Fernandez-Rodriguez, Conrado M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740721/
https://www.ncbi.nlm.nih.gov/pubmed/29268704
http://dx.doi.org/10.1186/s12876-017-0726-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740721/
https://www.ncbi.nlm.nih.gov/pubmed/29268704
http://dx.doi.org/10.1186/s12876-017-0726-2

Ejemplares similares